title: Co-amplification of erbB2, topoisomerase II alpha and retinoic acid receptor alpha genes in breast cancer and allelic loss at topoisomerase I on chromosome 20.
abstract: The DNA topoisomerase enzymes are targets for the cytotoxic effects of a number of anticancer agents termed topoisomerase inhibitors. We have analysed breast cancer biopsy specimens for genetic alterations at and around topoisomerase loci in order to obtain molecular insight into factors which may determine how tumours respond to chemotherapy. We show that of 50 tumours examined, the topoisomerase II alpha locus is co-amplified in 3 cases out of 6 with erbB2 amplification and that amplification can be accompanied by high expression of topoisomerase II alpha. In our attempts to distinguish amplification from aneuploidy and define the limits of amplification, we also observed co-amplification of the retinoic acid-alpha receptor with erbB2 and topoisomerase II alpha in the same three samples. At the topoisomerase I locus on chromosome 20, we observed allelic loss in two out of 17 samples. Genetics abberations at topoisomerase loci, therefore, appear to be relatively common in breast cancer.
authors.affiliation: CRC Department of Medical Oncology, Beatson Laboratories, Bearsden, Glasgow, U.K.
authors.forename: W N
authors.initials: WN
authors.lastname: Keith
authors.forename: F
authors.initials: F
authors.lastname: Douglas
authors.forename: G C
authors.initials: GC
authors.lastname: Wishart
authors.forename: H M
authors.initials: HM
authors.lastname: McCallum
authors.forename: W D
authors.initials: WD
authors.lastname: George
authors.forename: S B
authors.initials: SB
authors.lastname: Kaye
authors.forename: R
authors.initials: R
authors.lastname: Brown
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D001943:Breast Neoplasms / Q000235:genetics*; D002886:Chromosomes, Human, Pair 17; D004250:DNA Topoisomerases, Type II / Q000096:biosynthesis / Q000235:genetics*; D004273:DNA, Neoplasm / Q000032:analysis; D066246:ErbB Receptors / Q000378:metabolism*; D005260:Female; D005784:Gene Amplification; D006801:Humans; D008875:Middle Aged; D011518:Proto-Oncogene Proteins / Q000378:metabolism*; D018719:Erb-b2 Receptor Tyrosine Kinases; D018168:Receptors, Retinoic Acid / Q000235:genetics* / Q000378:metabolism; D014212:Tretinoin / Q000378:metabolism*
chemical_list: D004250:DNA Topoisomerases, Type II; D004273:DNA, Neoplasm; D066246:ErbB Receptors; D011518:Proto-Oncogene Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D018168:Receptors, Retinoic Acid; D014212:Tretinoin